Prostate cancer screening limited to a few thousand high risk men
The U.S. Preventive Services Task Force (USPSTF) updated its recommendations in September 2023, indicating that men aged 55 to 69 should discuss the potential benefits and harms of prostate-specific antigen (PSA) screening with their healthcare providers. For those interested in understanding the broader implications of health guidelines, this article provides insights on how healthcare recommendations … Read more